Form 8-K OMNIVISION TECHNOLOGIES For: Dec 02
�
�
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
�
�
FORM�8-K
�
CURRENT REPORT
Pursuant to Section�13 or 15(d)�of
The Securities Exchange Act of 1934
�
Date of Report (Date of earliest event reported)
�
December�2, 2014
�
�
OMNIVISION TECHNOLOGIES,�INC.
(Exact name of registrant as specified in its charter)
�
Delaware |
� |
000-29939 |
� |
77-0401990 |
(State or other jurisdiction of |
� |
(Commission File Number) |
� |
(IRS Employer |
�
4275 Burton Drive
Santa Clara, California 95054
(Address of principal executive offices, including zip code)
�
(408) 567-3000
(Registrant�s telephone number, including area code)
�
�
(Former name or former address, if changed since last report)
�
Check the appropriate box below if the Form�8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
�
o����������� Written communications pursuant to Rule�425 under the Securities Act (17 CFR 230.425)
�
o����������� Soliciting material pursuant to Rule�14a-12 under the Exchange Act (17 CFR 240.14a-12)
�
o����������� Pre-commencement communications pursuant to Rule�14d-2(b)�under the Exchange Act (17 CFR 240.14d-2(b))
�
o����������� Pre-commencement communications pursuant to Rule�13e-4(c)�under the Exchange Act (17 CFR 240.13e-4(c))
�
�
�
�
Section�2 � Financial Information
�
Item 2.02������������� Results of Operations and Financial Condition.
�
The following information is intended to be furnished under Item 2.02 of Form�8-K, �Results of Operations and Financial Condition.�� This information shall not be deemed �filed� for purposes of Section�18 of the Securities Exchange Act of 1934, as amended (the �Exchange Act�), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
�
On December�2, 2014 OmniVision Technologies,�Inc. issued a press release announcing its financial results for the second quarter of fiscal 2015 that ended on October�31, 2014. The full text of the press release is attached hereto as Exhibit�99.1 and is incorporated herein by reference.
�
Section�9 � Financial Statements and Exhibits
�
Item 9.01.� Financial Statements and Exhibits.
�
(d)� Exhibits.
�
The following exhibit is furnished herewith:
�
Exhibit�No. |
� |
Description |
99.1 |
� |
Press Release, dated December�2, 2014 of OmniVision Technologies,�Inc. announcing its financial results for its second quarter of fiscal 2015 ended October�31, 2014. |
�
�
SIGNATURES
�
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
�
� |
� |
OMNIVISION TECHNOLOGIES,�INC. |
� |
� |
� |
� |
By: |
/s/ Shaw Hong |
� |
� |
Shaw Hong |
� |
� |
Chief Executive Officer |
�
�
Date:� December�2, 2014
�
�
EXHIBIT�INDEX
�
Exhibit�No. |
� |
Description |
� |
� |
� |
99.1 |
� |
Press Release, dated December�2, 2014 of OmniVision Technologies,�Inc. announcing its financial results for its second quarter of fiscal 2015 ended October�31, 2014. |
�
Exhibit 99.1
�
�
OMNIVISION REPORTS FINANCIAL RESULTS
FOR THE SECOND QUARTER OF FISCAL�2015
�
SANTA CLARA, Calif.,���December�2, 2014���OmniVision Technologies,�Inc. (Nasdaq: OVTI), a leading developer of advanced digital imaging solutions, today reported financial results for the second quarter of fiscal 2015 that ended on October�31, 2014.
�
Revenues for the second quarter of fiscal�2015 were $394.0�million, as compared to $406.5�million in the first quarter of fiscal�2015, and $397.2�million in the second quarter of fiscal�2014. GAAP net income in the second quarter of fiscal�2015 was $28.0�million, or $0.47�per diluted share, as compared to net income of $45.3�million, or $0.78�per diluted share in the first quarter of fiscal�2015, and $26.3�million, or $0.47�per diluted share in the second quarter of fiscal�2014.
�
Non-GAAP net income in the second quarter of fiscal�2015 was $36.9�million, or $0.60�per diluted share. Non-GAAP net income in the first quarter of fiscal�2015 was $54.4�million, or $0.91�per diluted share. Non-GAAP net income in the second quarter of fiscal�2014 was $34.9�million, or $0.60�per diluted share. Non-GAAP net income excludes stock-based compensation expenses and the related tax effects. Please refer to the attached schedule for a reconciliation of GAAP net income to non-GAAP net income for the three and six months ended October�31, 2014 and 2013 and for the three months ended July�31, 2014.
�
GAAP gross margin for the second quarter of fiscal�2015 was 22.0%, as compared to 21.7% for the first quarter of fiscal�2015 and 18.8% for the second quarter of fiscal�2014. The sequential increase in second quarter gross margin reflected an increase in revenues recorded on the sale of previously written-down inventory and a continued mix shift towards our newer generation products.
�
The Company ended the period with cash, cash equivalents and short-term investments totaling $525.2�million, a slight increase of $1.0�million from the previous quarter.
�
�Our mobile phone and automotive products continue to be the drivers behind our strong results this quarter,� said Shaw Hong, chief executive officer of OmniVision Technologies,�Inc. �We are pleased with our execution in China, and with the emergence of India as a key geography for us. We are also excited about the launch of our high-performance stacked-die PureCel-S products, which demonstrates our technology leadership.�
�
�
Outlook
�
Based on current trends, the Company expects revenues for the third quarter of fiscal�2015 will be in the range of $275�million to $305�million and GAAP net income per share will be between $0.09�and $0.25�per diluted share. Excluding the estimated expense and related tax effects associated with stock-based compensation, the Company expects its non-GAAP net income per share will be between $0.22�and $0.38�per diluted share. Refer to the table below for a reconciliation of GAAP to non-GAAP net income. The estimated GAAP and non-GAAP net income per share include an anticipated reduction in unrecognized tax benefits of approximately $3.0�million, resulting from the conclusion of a foreign jurisdiction tax examination.
�
Conference Call
�
OmniVision Technologies,�Inc. will host a conference call today at 5:00�p.m. Eastern time to discuss these results further. This conference call can be accessed via a webcast at www.ovt.com. The call can also be accessed by dialing 877-299-4454�(domestic) or 617-597-5447�(international) and entering passcode�29096693.
�
A replay of the call will remain available at www.ovt.com for approximately twelve months. A replay of the call will also be available for one week beginning approximately one hour after the conclusion of the call. To access the replay, dial 888-286-8010�(domestic) or 617-801-6888�(international) and enter passcode�34461414.
�
About OmniVision
�
OmniVision Technologies,�Inc. is a leading developer of advanced digital imaging solutions. Its CameraChip� and CameraCubeChip� products are highly integrated, single-chip CMOS image sensors for consumer and commercial applications, including mobile phones, tablets and entertainment devices, notebooks and webcams, security and surveillance systems, digital still and video cameras, automotive and medical imaging systems. Additional information is available at www.ovt.com.
�
�
Safe Harbor Statement
�
Certain statements in this press release, including statements regarding our mobile phone and automotive products continuing to be drivers for our business, the emergence of India as a key geography for us, the launch of our high-performance stacked-die PureCel-S products, and statements regarding our expectations regarding revenues and earnings per share for the three months ending January�31, 2015 are forward-looking statements. These forward-looking statements are based on management�s current expectations, and certain factors could cause actual results to differ materially from those in the forward-looking statements. These factors include, without limitation, our ability to maintain or increase sales to current key customers and end-users of our products; competition in current and emerging markets for image sensor products, including pricing pressures that could result from competition; our ability to increase the average selling prices or lower the costs associated with the development and manufacture of our new, complex products and technologies; the potential for a slowdown in sales in the near term due to an inventory build by our customers in the earlier part of the year; fluctuations of wafer manufacturing costs, manufacturing yields, manufacturing capacity and other manufacturing processes and the impact on gross margins; the continued growth and development of current markets and the emergence of new markets in which we sell, or may sell, our products; fluctuations in sales mix and average selling prices; our ability to timely complete the product development cycle for new sensors; our ability to obtain design wins from various image sensor device manufacturers including manufacturers of mobile phones, tablets and entertainment devices, notebooks and webcams, security and surveillance systems, digital still and video cameras, automotive and medical imaging systems; our dependence on third party wafer foundries and their ability to manufacture our wafers in the required quantities, at acceptable quality, yields and costs, and in a timely manner; our ability to accurately forecast customer demand for our products; the impact of general economic conditions on orders from the end-user customers of our products; the market acceptance of products into which our products are designed; the development, production, introduction and marketing of new products and technology; the occurrence of litigation regarding intellectual property or indemnification claims from our suppliers or customers relating to our intellectual property; our strategic investments and relationships, and other risks detailed from time to time in our Securities and Exchange Commission filings and reports, including, but not limited to, our most recent Annual Report on Form�10-K and recent Quarterly Reports on Form�10-Q. We expressly disclaim any obligation to update information contained in any forward-looking statement.
�
Use of Non-GAAP Financial Information
�
To supplement the reader�s overall understanding of both its reported results presented in accordance with U.S. generally accepted accounting principles (�GAAP�) and its outlook, the Company also presents non-GAAP measures of net income and net income per share which are adjusted from results based on GAAP. In particular, the Company excludes stock-based compensation expenses and the related tax effects. The non-GAAP financial measures which the Company discloses also exclude the effects of stock-based compensation on the number of basic and diluted common shares used in calculating non-GAAP basic and diluted net income per share. The Company provides these non-GAAP financial measures to enhance an investor�s overall understanding of its current financial performance and to assess its prospects for the future. These non-GAAP financial measures reflect an additional way of viewing aspects of the Company�s operations that, when viewed with its GAAP results and the accompanying
�
�
reconciliations to the corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting the Company�s business. The economic basis for the Company�s decision to use non-GAAP financial measures is that the adjustments to net income did not reflect the on-going relative strength of the Company�s performance. The Company�s objective is to minimize any confusion in the financial markets by providing non-GAAP net income and non-GAAP net income per share measurements and disclosing the related components. These non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, the financial measures prepared in accordance with GAAP.
�
The Company uses non-GAAP financial measures for internal management purposes to conduct and evaluate its business, when publicly providing its business outlook and to facilitate period-to-period comparisons. The Company views non-GAAP net income per share as a primary indicator of the profitability of its underlying business. In addition, because stock-based compensation is a non-cash expense and is offset in full by a credit to additional paid-in capital, it has no effect on total stockholders� equity. As the calculation of non-GAAP financial measures differs between companies, the non-GAAP financial measures used by the Company may not be comparable to similarly titled measures used by other companies. Other than stock-based compensation and the related tax effects, these differences may cause the Company�s non-GAAP measures to not be directly comparable to other companies� non-GAAP measures. Although these non-GAAP financial measures adjust cost, expenses and basic and diluted share items to exclude the accounting treatment of stock-based compensation, they should not be viewed as a non-GAAP presentation reflecting the elimination of the underlying stock-based compensation programs. Thus, the Company�s non-GAAP presentations are not intended to present, and should not be used, as a basis for assessing what its operating results might be if it were to eliminate its stock-based compensation programs. The Company compensates for these limitations by providing full disclosure of the net income and net income per share on a basis prepared in accordance with GAAP to enable investors to consider net income and net income per share determined under GAAP as well as on an adjusted basis, and perform their own analysis, as appropriate. As a result of the foregoing limitations, the Company does not use, nor does the Company intend to use, the non-GAAP financial measures when assessing the Company�s performance against that of other companies.
�
Estimating stock-based compensation expenses and the related tax effects for a future period is subject to inherent risks and uncertainties, including but not limited to the price of the Company�s stock, stock market volatility, expected option life, risk-free interest rates, and the number of option exercises and sales during the quarter.
�
�
OMNIVISION TECHNOLOGIES,�INC.
�
RECONCILIATION OF GUIDANCE FOR GAAP NET INCOME PER DILUTED SHARE
TO PROJECTED NON-GAAP NET INCOME PER DILUTED SHARE
(unaudited)
�
� |
� |
Three�Months�Ending�January�31,�2015 |
� | |||||||||||||
� |
� |
GAAP |
� |
� |
� |
Non-GAAP |
� | |||||||||
� |
� |
From |
� |
To |
� |
Adjustment |
� |
From |
� |
To |
� | |||||
Net income per share |
� |
$ |
0.09 |
� |
$ |
0.25 |
� |
$ |
0.13 |
(1) |
$ |
0.22 |
� |
$ |
0.38 |
� |
�
(1)������ Reflects estimated adjustment for expenses and related tax effects associated with stock-based compensation.
�
�
OMNIVISION TECHNOLOGIES,�INC.
�
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share amounts)
(unaudited)
�
� |
� |
October�31, |
� |
April�30, |
� | ||
� |
� |
2014 |
� |
2014 |
� | ||
ASSETS |
� |
� |
� |
� |
� | ||
Current assets: |
� |
� |
� |
� |
� | ||
Cash and cash equivalents |
� |
$ |
313,995 |
� |
$ |
297,952 |
� |
Short-term investments |
� |
211,170 |
� |
152,993 |
� | ||
Accounts receivable, net |
� |
171,805 |
� |
172,472 |
� | ||
Inventories |
� |
340,036 |
� |
270,935 |
� | ||
Deferred income taxes |
� |
3,415 |
� |
4,973 |
� | ||
Prepaid expenses and other current assets |
� |
14,854 |
� |
6,576 |
� | ||
Total current assets |
� |
1,055,275 |
� |
905,901 |
� | ||
Property, plant and equipment, net |
� |
149,482 |
� |
153,792 |
� | ||
Long-term investments |
� |
143,149 |
� |
154,409 |
� | ||
Goodwill |
� |
10,227 |
� |
10,227 |
� | ||
Intangibles, net |
� |
59,232 |
� |
66,217 |
� | ||
Other long-term assets |
� |
24,669 |
� |
32,529 |
� | ||
Total assets |
� |
$ |
1,442,034 |
� |
$ |
1,323,075 |
� |
� |
� |
� |
� |
� |
� | ||
LIABILITIES AND STOCKHOLDERS� EQUITY |
� |
� |
� |
� |
� | ||
Current liabilities: |
� |
� |
� |
� |
� | ||
Accounts payable |
� |
$ |
181,960 |
� |
$ |
142,012 |
� |
Accrued expenses and other current liabilities |
� |
33,574 |
� |
31,959 |
� | ||
Income taxes payable |
� |
7,364 |
� |
2,316 |
� | ||
Deferred revenues, less cost of revenues |
� |
20,368 |
� |
25,783 |
� | ||
Current portion of long-term debt |
� |
3,808 |
� |
3,802 |
� | ||
Total current liabilities |
� |
247,074 |
� |
205,872 |
� | ||
Long-term liabilities: |
� |
� |
� |
� |
� | ||
Long-term income taxes payable |
� |
56,699 |
� |
86,498 |
� | ||
Non-current portion of long-term debt |
� |
31,771 |
� |
32,030 |
� | ||
Other long-term liabilities |
� |
23,819 |
� |
11,818 |
� | ||
Total long-term liabilities |
� |
112,289 |
� |
130,346 |
� | ||
Total liabilities |
� |
359,363 |
� |
336,218 |
� | ||
� |
� |
� |
� |
� |
� | ||
Stockholders� equity: |
� |
� |
� |
� |
� | ||
Common stock, $0.001 par value; 100,000�shares authorized; 78,261�shares issued and 57,662�outstanding at October�31, 2014 and 76,681�shares issued and 56,082�outstanding at April�30, 2014, respectively |
� |
78 |
� |
77 |
� | ||
Additional paid-in capital |
� |
687,070 |
� |
664,602 |
� | ||
Accumulated other comprehensive income |
� |
2,352 |
� |
2,378 |
� | ||
Treasury stock, 20,599 at October�31, 2014 and April�30, 2014, respectively |
� |
(278,683 |
) |
(278,683 |
) | ||
Retained earnings |
� |
671,854 |
� |
598,483 |
� | ||
Total stockholders� equity |
� |
1,082,671 |
� |
986,857 |
� | ||
Total liabilities and stockholders� equity |
� |
$ |
1,442,034 |
� |
$ |
1,323,075 |
� |
�
�
OMNIVISION TECHNOLOGIES,�INC.
�
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(in thousands, except per share amounts)
(unaudited)
�
� |
� |
Three�Months�Ended |
� |
Six�Months�Ended |
� | ||||||||
� |
� |
October�31, |
� |
October�31, |
� | ||||||||
� |
� |
2014 |
� |
2013 |
� |
2014 |
� |
2013 |
� | ||||
Revenues |
� |
$ |
394,045 |
� |
$ |
397,249 |
� |
$ |
800,581 |
� |
$ |
770,937 |
� |
Cost of revenues |
� |
307,548 |
� |
322,383 |
� |
625,664 |
� |
630,910 |
� | ||||
Gross profit |
� |
86,497 |
� |
74,866 |
� |
174,917 |
� |
140,027 |
� | ||||
� |
� |
� |
� |
� |
� |
� |
� |
� |
� | ||||
Operating expenses: |
� |
� |
� |
� |
� |
� |
� |
� |
� | ||||
Research, development and related |
� |
34,186 |
� |
29,123 |
� |
68,918 |
� |
56,825 |
� | ||||
Selling, general and administrative |
� |
20,229 |
� |
18,456 |
� |
39,439 |
� |
36,656 |
� | ||||
Amortization of acquired patent portfolio |
� |
2,322 |
� |
2,322 |
� |
4,643 |
� |
4,643 |
� | ||||
Total operating expenses |
� |
56,737 |
� |
49,901 |
� |
113,000 |
� |
98,124 |
� | ||||
� |
� |
� |
� |
� |
� |
� |
� |
� |
� | ||||
Income from operations |
� |
29,760 |
� |
24,965 |
� |
61,917 |
� |
41,903 |
� | ||||
Equity in earnings of investee |
� |
1,034 |
� |
1,317 |
� |
1,969 |
� |
2,427 |
� | ||||
Interest expense, net |
� |
(397 |
) |
(535 |
) |
(852 |
) |
(1,076 |
) | ||||
Other income, net |
� |
219 |
� |
2,345 |
� |
1,264 |
� |
1,168 |
� | ||||
Income before income taxes |
� |
30,616 |
� |
28,092 |
� |
64,298 |
� |
44,422 |
� | ||||
� |
� |
� |
� |
� |
� |
� |
� |
� |
� | ||||
Provision for (benefit from) income taxes |
� |
2,572 |
� |
1,789 |
� |
(9,073 |
) |
(4,942 |
) | ||||
Net income |
� |
$ |
28,044 |
� |
$ |
26,303 |
� |
$ |
73,371 |
� |
$ |
49,364 |
� |
� |
� |
� |
� |
� |
� |
� |
� |
� |
� | ||||
Net income per share: |
� |
� |
� |
� |
� |
� |
� |
� |
� | ||||
Basic |
� |
$ |
0.49 |
� |
$ |
0.47 |
� |
$ |
1.28 |
� |
$ |
0.90 |
� |
Diluted |
� |
$ |
0.47 |
� |
$ |
0.47 |
� |
$ |
1.25 |
� |
$ |
0.89 |
� |
� |
� |
� |
� |
� |
� |
� |
� |
� |
� | ||||
Shares used in computing net income per share: |
� |
� |
� |
� |
� |
� |
� |
� |
� | ||||
Basic |
� |
57,617 |
� |
55,584 |
� |
57,100 |
� |
55,098 |
� | ||||
Diluted |
� |
59,423 |
� |
55,732 |
� |
58,790 |
� |
55,453 |
� |
�
�
OMNIVISION TECHNOLOGIES,�INC.
�
RECONCILIATION OF GAAP NET INCOME TO NON-GAAP NET INCOME
(in thousands, except per share amounts)
(unaudited)
�
� |
� |
Three�Months�Ended |
� |
Six�Months�Ended |
� |
Three�Months |
� | |||||||||
� |
� |
October�31, |
� |
October�31, |
� |
July�31, |
� | |||||||||
� |
� |
2014 |
� |
2013 |
� |
2014 |
� |
2013 |
� |
2014 |
� | |||||
GAAP net income |
� |
$ |
28,044 |
� |
$ |
26,303 |
� |
$ |
73,371 |
� |
$ |
49,364 |
� |
$ |
45,327 |
� |
Add: |
� |
� |
� |
� |
� |
� |
� |
� |
� |
� |
� | |||||
Stock-based compensation in cost of revenues |
� |
1,166 |
� |
985 |
� |
2,151 |
� |
1,957 |
� |
985 |
� | |||||
Stock-based compensation in research, development and related expenses |
� |
4,209 |
� |
3,936 |
� |
8,469 |
� |
7,730 |
� |
4,260 |
� | |||||
Stock-based compensation in selling, general and administrative expenses |
� |
3,280 |
� |
3,552 |
� |
6,484 |
� |
7,282 |
� |
3,204 |
� | |||||
Decrease in provision for (benefit from) income taxes without the effect of stock-based compensation |
� |
232 |
� |
159 |
� |
834 |
� |
329 |
� |
602 |
� | |||||
Non-GAAP net income |
� |
$ |
36,931 |
� |
$ |
34,935 |
� |
$ |
91,309 |
� |
$ |
66,662 |
� |
$ |
54,378 |
� |
� |
� |
� |
� |
� |
� |
� |
� |
� |
� |
� |
� | |||||
GAAP provision for (benefit from) income taxes |
� |
$ |
2,572 |
� |
$ |
1,789 |
� |
$ |
(9,073 |
) |
$ |
(4,942 |
) |
$ |
(11,645 |
) |
Decrease in provision for (benefit from) income taxes without the effect of stock-based compensation |
� |
232 |
� |
159 |
� |
834 |
� |
329 |
� |
602 |
� | |||||
Non-GAAP provision for (benefit from) income taxes |
� |
$ |
2,340 |
� |
$ |
1,630 |
� |
$ |
(9,907 |
) |
$ |
(5,271 |
) |
$ |
(12,247 |
) |
� |
� |
� |
� |
� |
� |
� |
� |
� |
� |
� |
� | |||||
Non-GAAP net income per share: |
� |
� |
� |
� |
� |
� |
� |
� |
� |
� |
� | |||||
Basic |
� |
$ |
0.64 |
� |
$ |
0.63 |
� |
$ |
1.60 |
� |
$ |
1.21 |
� |
$ |
0.96 |
� |
Diluted |
� |
$ |
0.60 |
� |
$ |
0.60 |
� |
$ |
1.50 |
� |
$ |
1.15 |
� |
$ |
0.91 |
� |
� |
� |
� |
� |
� |
� |
� |
� |
� |
� |
� |
� | |||||
Shares used in computing non-GAAP net income per share: |
� |
� |
� |
� |
� |
� |
� |
� |
� |
� |
� | |||||
Basic |
� |
57,617 |
� |
55,584 |
� |
57,100 |
� |
55,098 |
� |
56,583 |
� | |||||
Diluted |
� |
61,730 |
� |
58,649 |
� |
60,905 |
� |
58,083 |
� |
60,081 |
� |
�
Contact Information
Investor Relations:
Arnab Chanda
OmniVision Technologies,�Inc.
408.653.3144
�
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dicello Levitt LLP Announces Investor Class Action Lawsuit Filed Against QuidelOrtho Corp. f/k/a Quidel Corp. (NASDAQ: QDEL) And Lead Plaintiff Deadline
- GLOBAL CORD ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Global Cord Blood Corporation and Encourages Investors to Contact the Firm
- Perk Labs Announces Closing of Non-Brokered Private Placements
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!